Top midcap gainers: NLC India, Lupin, Supreme Industries stocks lead on Nifty Midcap 150 index today

At 9:30 am on Friday, several stocks were identified as top gainers on the Nifty Midcap 150. NLC India led the gains at Rs 264.60, up by 3.25%. Other notable gainers included Lupin, Supreme Ind, Astral Ltd, and Bharat Forge.

Financial Highlights of NLC India

NLC India's financial performance shows a fluctuating but overall positive trend. The consolidated revenue for the year-ending March 2025 stood at Rs 15,282.96 Crore, compared to Rs 12,999.03 Crore in the previous year. Net profit also saw a significant increase, reaching Rs 2,713.37 Crore in March 2025 from Rs 1,867.32 Crore in March 2024. The company’s EPS stood at Rs 19.57.The company’s debt-to-equity ratio stood at 1.20.

The following table summarizes the key financial figures for NLC India:

NLC India's quarterly financial results indicate consistent revenue. The revenue for June 2025 stood at Rs 3,825.61 Crore, slightly down from Rs 3,836.00 Crore in March 2025. Net profit for the same period was Rs 839.15 Crore, up from Rs 468.36 Crore in the previous quarter. The EPS stood at Rs 5.02. The company’s financial performance demonstrates its ability to maintain profitability.Corporate Announcements for NLC India

Recent announcements from NLC India include the signing of a Memorandum of Understanding with Khanij Bidesh India Limited. Other announcements include appointment of Statutory Auditor and regarding Newspaper Publication.

NLC India declared a final dividend of Rs 1.50 per share(15%) with effective date as 19 Sep, 2025. The company also announced an interim dividend of Rs 1.50 per share(15%) with effective date as 07 Feb, 2025.

Financials of Lupin

Lupin's consolidated revenue for the year-ending March 2025 stood at Rs 22,707.90 Crore, compared to Rs 20,010.82 Crore in the previous year. Net profit also saw a significant increase, reaching Rs 3,306.26 Crore in March 2025 from Rs 1,935.57 Crore in March 2024. The company’s EPS stood at Rs 71.95. The company's debt-to-equity ratio stood at 0.30.

Lupin's quarterly financial results indicate increasing revenue. The revenue for June 2025 stood at Rs 6,268.34 Crore, up from Rs 5,667.13 Crore in March 2025. Net profit for the same period was Rs 1,221.46 Crore, up from Rs 782.38 Crore in the previous quarter. The EPS stood at Rs 26.70. These figures highlight Lupin's strong growth and profitability.Corporate Announcements for Lupin

Recent announcements from Lupin include Intimation about participating in the Analyst/Investors Meet. Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform.

Lupin declared a final dividend of Rs 12.00 per share (600%) with effective date as 25 Jul, 2025.

NLC India and Lupin emerged as top gainers on the Nifty Midcap 150, driven by positive financial results and recent corporate developments.